A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
A neutralizing human monoclonal antibody can fully protect nonhuman primates from disease after a lethal Hendra virus challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901 · cited 2×
“4 inNHPs, it will be critical to establish acceptable therapeutic guidelines pertinent to either accidental or natural exposure to HeV.”
BackgroundA summary of taxonomic changes recently approved by ICTV
Mayo, M. A. (2002) · Archives of Virology · doi:10.1007/s007050200039 · Cited by 811 · cited 1×
“Upon further biological, molecular, and serological characterization, HeV and NiV were discovered to be closely related viruses that had emerged independently and are now grouped together in the new genusHenipavirus (1, 2), and both are classified as select viral agents in the United States by the Centers for Disease…”
BackgroundEphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
Negrete, O. A., Levroney, E. L., Aguilar, H. C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., & Lee, B. (2005) · Nature · doi:10.1038/nature03838 · Cited by 570
Recurrent Zoonotic Transmission of Nipah Virus into Humans, Bangladesh, 2001–2007
Luby, S. P., Hossain, J., Gurley, E. S., Ahmed, B., Banu, S., Khan, S. U., Homaira, N., Rota, P. A., Rollin, P. E., Comer, J. A., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1508.081237 · Cited by 485 · cited 1×
“Notably, from2001 to 2007, more than half of the identified NiV cases resulted from personto-person transmission (7).”
BackgroundHendra and Nipah viruses: different and dangerous
Eaton, B. T., Broder, C. C., Middleton, D., & Wang, L.-F. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1323 · Cited by 482 · cited 3×
“In total, 15 horses and two of three infected humans succumbed to fatal HeV disease (1).”
BackgroundSelf-citationEphrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
Bonaparte, M. I., Dimitrov, A. S., Bossart, K. N., Crameri, G., Mungall, B. A., Bishop, K. A., Choudhry, V., Dimitrov, D. S., Wang, L.-F., Eaton, B. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504887102 · Cited by 479
Self-citationThe natural history of Hendra and Nipah viruses
Field, H., Young, P., Yob, J. M., Mills, J., Hall, L., & Mackenzie, J. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01384-3 · Cited by 424 · cited 1×
“As a group, they arewide-ranging and can be found throughout the Asia-Pacific, as far west as Africa, and as far north as India, Pakistan, and the Philippines (3, 4).”
BackgroundBossart, K. N., Zhu, Z., Middleton, D., Klippel, J., Crameri, G., Bingham, J., McEachern, J. A., Green, D., Hancock, T. J., Chan, Y.-P., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000642 · Cited by 345
Self-citationTwo Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus
Negrete, O. A., Wolf, M. C., Aguilar, H. C., Enterlein, S., Wang, W., Mühlberger, E., Su, S. V., Bertolotti-Ciarlet, A., Flick, R., & Lee, B. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020007 · Cited by 322
Human Hendra Virus Encephalitis Associated with Equine Outbreak, Australia, 2008
Playford, E. G., McCall, B., Smith, G. A., Slinko, V. G., Allen, G., Smith, I., Moore, F., Taylor, C. T., Kung, Y. H., & Field, H. E. (2010) · Emerging infectious diseases · doi:10.3201/eid1602.090552 · Cited by 220
Cited by
Cedar Virus: A Novel Henipavirus Isolated from Australian Bats
Marsh, G. A., de Jong, C., Barr, J. A., Tachedjian, M., Smith, C., Middleton, D., Yu, M., Todd, S., Foord, A. J., Haring, V., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002836 · Cited by 332
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Qiu, X., Audet, J., Wong, G., Pillet, S., Bello, A., Cabral, T., Strong, J. E., Plummer, F., Corbett, C. R., Alimonti, J. B., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003876 · Cited by 315
Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health
Middleton, D., Pallister, J., Klein, R., Feng, Y.-R., Haining, J., Arkinstall, R., Frazer, L., Huang, J.-A., Edwards, N., Wareing, M., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2003.131159 · Cited by 223
“Earlier reports have shown that passive immunotherapy with antibody to the G or F glycoprotein of HeV or Nipah virus alone can prevent fulminating disease (20): G glycoprotein–specific human monoclonal antibody prevented Nipah virus disease in ferrets (21) and HeV infection in African green monkeys (22); and F or G gl…”
BackgroundSelf-citationNipah Virus: Past Outbreaks and Future Containment
Soman Pillai, V., Krishna, G., & Valiya Veettil, M. (2020) · Viruses · doi:10.3390/v12040465 · Cited by 194
Monoclonal antibodies for prophylactic and therapeutic use against viral infections
Both, L., Banyard, A. C., van Dolleweerd, C., Wright, E., Ma, J. K.-C., & Fooks, A. R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.025 · Cited by 107
“Applications for antiviral mAbs may also include infections of the central nervous system (CNS) and several mAbs have shown promise in clearing established neurological diseases, including West Nile virus and Hendra virus infections [10,96].”
Structure and design of Langya virus glycoprotein antigens
Wang, Z., McCallum, M., Yan, L., Gibson, C. A., Sharkey, W., Park, Y.-J., Dang, H. V., Amaya, M., Person, A., Broder, C. C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314990121 · Cited by 32
Self-citationGriffin, B. D., Leung, A., Chan, M., Warner, B. M., Ranadheera, C., Tierney, K., Audet, J., Frost, K. L., Safronetz, D., Embury-Hyatt, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47549-y · Cited by 26
Metadata
- Authors
- Bossart, K. N., Geisbert, T. W., Feldmann, H., Zhu, Z., Feldmann, F., Geisbert, J. B., Yan, L., Feng, Y.-R., Brining, D., Scott, D., Wang, Y., Dimitrov, A. S., Callison, J., Chan, Y.-P., Hickey, A. C., Dimitrov, D. S., Broder, C. C., & Rockx, B.
- Venue
- Science Translational Medicine
- Published
- 2011-10-19
- Volume
- 3
- Issue
- 105
- Pages
- 105ra103-105ra103
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2054288808
- Cited by
- 179
- References
- 21
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.